Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. National Comprehensive Cancer Network. NCCN guidelines version 2.2020 prostate cancer. 2020. https://www.nccn.org. Accessed 21 Aug 2020.
2. European Association of Urology. Prostate cancer. 2020. https://www.uroweb.org/guideline/prostate-cancer/. Accessed 21 Aug 2020.
3. Katzenwadel A, Wolf P. Androgen deprivation of prostate cancer: leading to a therapeutic dead end. Cancer Lett. 2015;367(1):12–7.
4. Barata P, Swami U, Agarwal N. The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy. Expert Rev Anticancer Ther. 2020;20(3):147–50.
5. Janssen-Cilag International NV. Erleada (apalutamide): EU summary of product characteristics. 2020. https://www.ema.europa.eu/. Accessed 21 Aug 2020.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献